The drug regulator’s expert panel on Covid vaccines has recommended granting emergency use authorisation to Biological E’s Corbevax for use in children in the 5-11 years’ age group, official sources said on Thursday. The final approval to Corbevax by the Drugs Controller General of India (DCGI) is expected by next week.
from Times of India https://ift.tt/iunkrBx
via
0 Comments